These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29227978)

  • 1. Osterix Decreases the Chemosensitivity of Breast Cancer Cells by Upregulating GALNT14.
    Wu J; Chen X; Bao Q; Duan R; Jin Y; Shui Y; Yao B; Lu X; Wang Y; Cui H; Li L; Yuan H; Ma C
    Cell Physiol Biochem; 2017; 44(3):998-1010. PubMed ID: 29227978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated osterix promotes invasion and bone metastasis and predicts for a poor prognosis in breast cancer.
    Yao B; Wang J; Qu S; Liu Y; Jin Y; Lu J; Bao Q; Li L; Yuan H; Ma C
    Cell Death Dis; 2019 Jan; 10(1):28. PubMed ID: 30631043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
    Huanna T; Tao Z; Xiangfei W; Longfei A; Yuanyuan X; Jianhua W; Cuifang Z; Manjing J; Wenjing C; Shaochuan Q; Feifei X; Naikang L; Jinchao Z; Chen W
    Mol Carcinog; 2015 Oct; 54(10):1159-71. PubMed ID: 24962947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osterix promotes the migration and angiogenesis of breast cancer by upregulation of S100A4 expression.
    Qu S; Wu J; Bao Q; Yao B; Duan R; Chen X; Li L; Yuan H; Jin Y; Ma C
    J Cell Mol Med; 2019 Feb; 23(2):1116-1127. PubMed ID: 30450809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GALNT14 promotes lung-specific breast cancer metastasis by modulating self-renewal and interaction with the lung microenvironment.
    Song KH; Park MS; Nandu TS; Gadad S; Kim SC; Kim MY
    Nat Commun; 2016 Dec; 7():13796. PubMed ID: 27982029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted therapy against Bcl-2-related proteins in breast cancer cells.
    Emi M; Kim R; Tanabe K; Uchida Y; Toge T
    Breast Cancer Res; 2005; 7(6):R940-52. PubMed ID: 16280040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonistic interactions between osterix and pyrophosphate during cementum formation.
    Choi H; Liu Y; Jeong JK; Kim TH; Cho ES
    Bone; 2019 Aug; 125():8-15. PubMed ID: 31059863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 inhibits SP7/Osterix activity in the transcriptional program of osteoblast differentiation.
    Artigas N; Gámez B; Cubillos-Rojas M; Sánchez-de Diego C; Valer JA; Pons G; Rosa JL; Ventura F
    Cell Death Differ; 2017 Dec; 24(12):2022-2031. PubMed ID: 28777372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-125a regulates ovarian cancer proliferation and invasion by repressing GALNT14 expression.
    Yang J; Li G; Zhang K
    Biomed Pharmacother; 2016 May; 80():381-387. PubMed ID: 27133078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GALNT6, GALNT14, and Gal-3 in association with GDF-15 promotes drug resistance and stemness of breast cancer
    Gadwal A; Purohit P; Khokhar M; Vishnoi JR; Pareek P; Choudhary R; Elhence P; Banerjee M; Sharma P
    Growth Factors; 2024 May; 42(2):84-100. PubMed ID: 38889447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation-dependent osterix degradation negatively regulates osteoblast differentiation.
    Hoshikawa S; Shimizu K; Watahiki A; Chiba M; Saito K; Wei W; Fukumoto S; Inuzuka H
    FASEB J; 2020 Nov; 34(11):14930-14945. PubMed ID: 32931083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of immunohistochemistry assays to assess GALNT14 and FUT3/6 in clinical trials of dulanermin and drozitumab.
    Stern HM; Padilla M; Wagner K; Amler L; Ashkenazi A
    Clin Cancer Res; 2010 Mar; 16(5):1587-96. PubMed ID: 20179215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PARK2 promotes mitochondrial pathway of apoptosis and antimicrotubule drugs chemosensitivity
    Chen H; Li Y; Li Y; Chen Z; Xie L; Li W; Zhu Y; Xue H; Koeffler HP; Wu W; Hu K; Yin D
    Theranostics; 2020; 10(22):9984-10000. PubMed ID: 32929329
    [No Abstract]   [Full Text] [Related]  

  • 14. YY2 Promotes Osteoblast Differentiation by Upregulating Osterix Transcriptional Activity.
    Piao M; Lee SH; Kim MJ; Kim HS; Lee KY
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIRT7 has a critical role in bone formation by regulating lysine acylation of SP7/Osterix.
    Fukuda M; Yoshizawa T; Karim MF; Sobuz SU; Korogi W; Kobayasi D; Okanishi H; Tasaki M; Ono K; Sawa T; Sato Y; Chirifu M; Masuda T; Nakamura T; Tanoue H; Nakashima K; Kobashigawa Y; Morioka H; Bober E; Ohtsuki S; Yamagata Y; Ando Y; Oike Y; Araki N; Takeda S; Mizuta H; Yamagata K
    Nat Commun; 2018 Jul; 9(1):2833. PubMed ID: 30026585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypeptide N-Acetylgalactosaminyltransferase 14 (GALNT14) as a Chemosensitivity-Related Biomarker for Osteosarcoma.
    Xi Q; Ma J
    J Oncol; 2023; 2023():1083423. PubMed ID: 38024474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of GALNT14 in lung metastasis of breast cancer.
    Kim MY
    BMB Rep; 2017 May; 50(5):233-234. PubMed ID: 28347399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osterix-Cre marks distinct subsets of CD45- and CD45+ stromal populations in extra-skeletal tumors with pro-tumorigenic characteristics.
    Ricci B; Tycksen E; Celik H; Belle JI; Fontana F; Civitelli R; Faccio R
    Elife; 2020 Aug; 9():. PubMed ID: 32755539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of fibrillin-2 and periostin expression in Osterix-knockdown MC3T3-E1 cells.
    Lee SJ; Lee EH; Park SY; Kim JE
    Gene; 2017 Jan; 596():123-129. PubMed ID: 27751812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of Macf1 in osterix expressing cells decreases bone formation by Bmp2/Smad/Runx2 pathway.
    Qiu WX; Ma XL; Lin X; Zhao F; Li DJ; Chen ZH; Zhang KW; Zhang R; Wang P; Xiao YY; Miao ZP; Dang K; Wu XY; Qian AR
    J Cell Mol Med; 2020 Jan; 24(1):317-327. PubMed ID: 31709715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.